GILEAD SCIENCES, INC. (GILD) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Gilead Sciences, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Gilead Sciences, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was $10.7 B, a 30% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $10.7 B -$4.57 B -30% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $16.3 B +$617 M +3.93% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $16 B +$246 M +1.56% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $15.1 B +$21 M +0.14% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $15.2 B +$237 M +1.58% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $15.7 B -$637 M -3.9% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $15.8 B -$1.15 B -6.79% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $15.1 B -$275 M -1.79% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $15 B +$165 M +1.11% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $16.3 B +$1.94 B +13.5% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $16.9 B +$3.19 B +23.3% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $15.4 B +$947 M +6.56% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $14.8 B -$3.89 B -20.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $14.4 B -$5.01 B -25.8% Dec 31, 2020 10-K 2022-02-23
Q3 2020 $13.7 B -$3.91 B -22.2% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $14.4 B -$5.38 B -27.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $18.7 B -$617 M -3.19% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $19.4 B +$364 M +1.91% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $17.6 B -$3.09 B -14.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $19.8 B +$4 M +0.02% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $19.3 B +$130 M +0.68% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $19 B +$12 M +0.06% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $20.7 B -$2.98 B -12.6% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $19.8 B -$2 B -9.16% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $19.2 B -$368 M -1.88% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $19 B +$858 M +4.73% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $23.7 B +$7.04 B +42.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $21.8 B +$6.87 B +46% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $19.6 B +$6.52 B +50% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $18.2 B +$153 M +0.85% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $16.7 B -$307 M -1.81% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $14.9 B -$1.09 B -6.79% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $13 B -$871 M -6.26% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $18 B +$5.27 B +41.4% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $17 B +$5.71 B +50.8% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $16 B +$5.84 B +57.2% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $13.9 B +$6.18 B +79.9% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $12.7 B +$6.63 B +109% Dec 31, 2014 10-K 2016-02-24
Q3 2014 $11.2 B +$5.51 B +96.1% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $10.2 B +$5.13 B +101% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $7.73 B +$3.43 B +79.8% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $6.11 B +$2.4 B +64.8% Dec 31, 2013 10-K 2015-02-25
Q3 2013 $5.74 B +$2.6 B +82.7% Sep 30, 2013 10-Q 2013-10-31
Q2 2013 $5.07 B +$2.4 B +90.2% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $4.3 B +$2.12 B +97.4% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $3.7 B +$1.93 B +109% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $3.14 B +$1.82 B +138% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $2.66 B +$1.27 B +90.8% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 $2.18 B +$858 M +65% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $1.78 B +$593 M +50.1% Dec 31, 2011 10-K 2013-02-27
Q3 2011 $1.32 B +$200 M +17.8% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $1.4 B -$435 M -23.8% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $1.32 B -$1.37 B -50.9% Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $1.18 B Dec 31, 2010 10-K 2012-02-23
Q3 2010 $1.12 B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $1.83 B Jun 30, 2010 10-Q 2010-08-09
Q1 2010 $2.69 B Mar 31, 2010 10-Q 2010-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.